Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like Nemaura Medical Develops Rechargeable Transmitter For Sugarbeat July 31, 2017 Struggling The Medicines Company Deals Its Infectious Disease Biz to Melinta for $270M November 28, 2017 The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
Struggling The Medicines Company Deals Its Infectious Disease Biz to Melinta for $270M November 28, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
